How did institutional ownership shifts in Q2 2025 impact RXRX's overall Fintel Fund Sentiment score?

The Fintel Fund Sentiment Score, formerly known as the Ownership Accumulation Score, is a proprietary quantitative model designed to identify stocks experiencing the highest levels of institutional accumulation. This score ranges from 0 to 100, with 50 representing the average accumulation relative to its peers, and higher numbers indicating stronger buying interest from institutional funds.

The model incorporates several factors to determine the score, including:

• Total increase in disclosed owners: An increase in the number of institutions reporting a position in a stock generally contributes positively to the score.
• Changes in portfolio allocations: Funds increasing their allocation to a particular stock, even if they were existing holders, will also positively impact the score.
• Other metrics: The model also considers additional quantitative metrics related to institutional buying and selling activity.

While the exact Fintel Fund Sentiment Score for Recursion Pharmaceuticals (RXRX) for Q2 2025 is not directly available in the provided search results, shifts in institutional ownership during that quarter would directly influence this score. For instance, if a significant number of new institutions initiated positions in RXRX, or if existing institutional holders substantially increased their shareholdings, it would likely lead to an increase in RXRX's Fund Sentiment Score. Conversely, a decrease in the number of institutional owners or a reduction in their aggregate positions would tend to lower the score.

To get the precise Q2 2025 Fund Sentiment Score for RXRX and a detailed breakdown of the institutional ownership changes, users would typically access Fintel's platform, which provides real-time updates and historical data on institutional ownership via 13F and NPORT filings.

Access the Fintel RXRX page to locate the specific Fund Sentiment Score for Q2 2025.